Literature DB >> 17513298

Amyotrophic lateral sclerosis-associated copper/zinc superoxide dismutase mutations preferentially reduce the repulsive charge of the proteins.

Erik Sandelin1, Anna Nordlund, Peter M Andersen, Stefan S L Marklund, Mikael Oliveberg.   

Abstract

We provide bioinformatical evidence that protein charge plays a key role in the disease mechanism of amyotrophic lateral sclerosis (ALS). Analysis of 100 ALS-associated mutations in copper/zinc superoxide dismutase (SOD1) shows that these are site-selective with a preference to decrease the proteins' net repulsive charge. For each SOD1 monomer this charge is normally -6. Because biomolecules as a rule maintain net negative charge to assure solubility in the cellular interior, the result lends support to the hypothesis of protein aggregation as an initiating event in the ALS pathogenesis. The strength of the preferential reduction of repulsive charge is higher in SOD1-associated ALS than in other inherited protein disorders.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17513298     DOI: 10.1074/jbc.M700765200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  31 in total

1.  Mutant SOD1 forms ion channel: implications for ALS pathophysiology.

Authors:  Michael J Allen; Jérome J Lacroix; Srinivasan Ramachandran; Ricardo Capone; Jenny L Whitlock; Ghanashyam D Ghadge; Morton F Arnsdorf; Raymond P Roos; Ratnesh Lal
Journal:  Neurobiol Dis       Date:  2011-09-10       Impact factor: 5.996

2.  Folding without charges.

Authors:  Martin Kurnik; Linda Hedberg; Jens Danielsson; Mikael Oliveberg
Journal:  Proc Natl Acad Sci U S A       Date:  2012-03-27       Impact factor: 11.205

3.  Nonamyloid aggregates arising from mature copper/zinc superoxide dismutases resemble those observed in amyotrophic lateral sclerosis.

Authors:  Young-Mi Hwang; Peter B Stathopulos; Kristin Dimmick; Hong Yang; Hamid R Badiei; Ming Sze Tong; Jessica A O Rumfeldt; Pu Chen; Vassili Karanassios; Elizabeth M Meiering
Journal:  J Biol Chem       Date:  2010-10-25       Impact factor: 5.157

4.  ALS precursor finally shaken into fibrils.

Authors:  Frederic Rousseau; Joost Schymkowitz; Mikael Oliveberg
Journal:  Proc Natl Acad Sci U S A       Date:  2008-11-24       Impact factor: 11.205

5.  SOD1 mutations targeting surface hydrogen bonds promote amyotrophic lateral sclerosis without reducing apo-state stability.

Authors:  Roberth Byström; Peter M Andersen; Gerhard Gröbner; Mikael Oliveberg
Journal:  J Biol Chem       Date:  2010-02-26       Impact factor: 5.157

6.  Global structural motions from the strain of a single hydrogen bond.

Authors:  Jens Danielsson; Wael Awad; Kadhirvel Saraboji; Martin Kurnik; Lisa Lang; Lina Leinartaite; Stefan L Marklund; Derek T Logan; Mikael Oliveberg
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-19       Impact factor: 11.205

7.  Arresting amyloid with coulomb's law: acetylation of ALS-linked SOD1 by aspirin impedes aggregation.

Authors:  Alireza Abdolvahabi; Yunhua Shi; Nicholas R Rhodes; Nathan P Cook; Angel A Martí; Bryan F Shaw
Journal:  Biophys J       Date:  2015-03-10       Impact factor: 4.033

8.  Genome-wide association analysis reveals a SOD1 mutation in canine degenerative myelopathy that resembles amyotrophic lateral sclerosis.

Authors:  Tomoyuki Awano; Gary S Johnson; Claire M Wade; Martin L Katz; Gayle C Johnson; Jeremy F Taylor; Michele Perloski; Tara Biagi; Izabella Baranowska; Sam Long; Philip A March; Natasha J Olby; G Diane Shelton; Shahnawaz Khan; Dennis P O'Brien; Kerstin Lindblad-Toh; Joan R Coates
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-02       Impact factor: 11.205

9.  Exposure of hydrophobic surfaces initiates aggregation of diverse ALS-causing superoxide dismutase-1 mutants.

Authors:  Christian Münch; Anne Bertolotti
Journal:  J Mol Biol       Date:  2010-04-24       Impact factor: 5.469

10.  Variation in aggregation propensities among ALS-associated variants of SOD1: correlation to human disease.

Authors:  Mercedes Prudencio; P John Hart; David R Borchelt; Peter M Andersen
Journal:  Hum Mol Genet       Date:  2009-05-30       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.